Explore 6 hopeful Alzheimer’s treatment paths, from innovative therapies to promising research, offering new possibilities ...

There's new research linking senolytics to helping slow down Alzheimer's progression. Here's how and what experts have to say ...

Anavex could secure conditional approval for blarcamesine, though longer trials may be needed. Check out why AVXL stock is a ...

A pause to NIH funding has researchers scrambling for contingency plans at the University of Washington’s Alzheimer’s Disease ...